Oaktree Acquisition Corp. III Life Sciences Class A (OACC)
NASDAQ: OACCFinanceBlank ChecksUSD
Market open · Delayed 15 min · as of Oct 8, 10:22 AM ET
OACC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $264.51M
- P/E (TTM)
- 38.43
- EPS (TTM)
- $0.28
- Dividend yield
- None
- 52-week range
- 10.50 – 10.88
- Day range
- 10.76 – 10.76
- Volume / Avg
- 3.64K / 30.07K
- Beta
- —
- Shares outstanding
- 19.78M
52-week range
OACC stock today
Oaktree Acquisition III Life Sciences (OACC) is trading at $10.76 on Oct 8, essentially unchanged from the prior close, versus the S&P 500's 0.34% decline. At this level, OACC sits in the middle of its 52-week range of $10.50 to $10.88: 1.1% below the high, set on Jul 30, 2026 and 2.5% above the low. OACC is up 1.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 2.2%.
Oaktree Acquisition III Life Sciences trades at 38.4x its trailing twelve-month earnings per share of $0.28.
Summary generated from market data by MetaCap's automated system. Methodology
About Oaktree Acquisition III Life Sciences
Company profileOaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
- Sector
- Finance
- Industry
- Blank Checks
- CEO
- Mr. Zaid Pardesi
- Headquarters
- Los Angeles, CA
- IPO year
- 2024
Oaktree Acquisition III Life Sciences peers
Finance sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XTERKarman Line Acquisition Corp. Class A | 9.79 | 0.00% | $267.43M | vs OACC |
| CATLCatalyst Acquisition Corp. Class A | 9.86 | +0.05% | $267.76M | vs OACC |
| TRGSTRG Latin America Acquisitions Corp. Class A | 9.97 | 0.00% | $259.37M | vs OACC |
| DNMXDynamix Corporation III Class A | 10.08 | 0.00% | $270.48M | vs OACC |
| THEOBOA Acquisition Corp. II Class A | 9.90 | 0.00% | $258.53M | vs OACC |
| VNMEVendome Acquisition Corporation I Class A | 10.31 | 0.00% | $257.75M | vs OACC |
| MUZEMuzero Acquisition Corp Class A | 10.01 | 0.00% | $273.48M | vs OACC |
| CEPOCantor Equity Partners I Inc. Class A | 10.77 | 0.00% | $274.64M | vs OACC |
Indexes, lists and sector
Oaktree Acquisition III Life Sciences stock FAQ
What is Oaktree Acquisition III Life Sciences's stock price today?
OACC last traded at $10.76 as of Oct 8, 10:22 AM EDT, up 0.00% on the day. Prices are delayed at least 15 minutes.
What is OACC's P/E ratio?
OACC trades at a trailing P/E ratio of 38.43.
Who is Oaktree Acquisition III Life Sciences's CEO?
Mr. Zaid Pardesi is the chief executive officer of Oaktree Acquisition Corp. III Life Sciences Class A.
What is the OACC 52-week high?
The 52-week high for OACC is $10.88 and the 52-week low is $10.50. The stock is currently 1.1% below its high.